54436-022Level 3
Otrexup (methotrexate)
**Product type:** Human Prescription Drug
**Active ingredient:** METHOTREXATE
**Strength:** 22.5 mg/.4mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Antares Pharma, Inc.
**Marketing category:** NDA (NDA204824)
**Pharmacologic class:** Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/54436-022Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.